Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 501-525 of 794 matching filings.

Per page
25
Current page
21
8-K File 001-37587

8-K

Filing date
17 Jul 2018
Reporting date
12 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214418

424B5

Filing date
13 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214418

FILED PURSUANT TO RULE 424(B)(5)

Filing date
10 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

FORM 8-K

Filing date
10 Jul 2018
Reporting date
10 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Jul 2018
Reporting date
05 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2018
Reporting date
03 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2018
Reporting date
01 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
04 Jun 2018
Reporting date
04 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
22 May 2018
Reporting date
22 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
16 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
09 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 May 2018
Reporting date
01 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 May 2018
Reporting date
01 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37587

DEFINITIVE PROXY STATEMENT

Filing date
26 Apr 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .